European Patients Forum, logo.

Amplifying Patient Advocacy on Antimicrobial Resistance (AMR)

Understanding Antimicrobial Resistance (AMR) and its impact on patients. The AMR Info Point is dedicated to providing extensive resources on AMR. Our goal is to improve awareness and understanding of AMR among patient communities.

HTA Info Point

Patient Involvement in Health Technology Assessment (HTA)

Health Technology Assessment (HTA) is a systematic evaluation process used to assess the properties, effects, and impacts of health technology. This includes not just medical devices and equipment, but also drugs, medical procedures, and broader healthcare policies and systems.

Knowledge Hub on Artificial Intelligence in Healthcare

The AI Knowledge Hub is dedicated to help patient organisations and other interested stakeholders to better engage in debates, projects and initiatives on AI in healthcare, both at national and European levels.

WHAT WE DO

Policy and advocacy, icon

Policy and advocacy

EPF is active in a number of policy areas to ensure that patients' views are incorporated into the EU policy agenda. We develop campaign and advocacy strategies

Projects icon

Projects

EPF has been active in various health-related EU projects over the past few years both as a leader or associate partner to gather patient-related evidence based information

Capacity building icon

Capacity building

The Capacity Building Programme was designed in 2012 to respond to needs and concerns which have been identified by our membership during previous activities of EPF.

NEWS AND UPDATES

20/01/26 EVENTS PATIENT EMPOWERMENT PATIENT INVOLVEMENT

EPF reaction to the adoption of the European Parliament position on the Critical Medicines Act (CMA)

The European Patients’ Forum welcomes the adoption of the European Parliament’s position on the CMA during today’s plenary session in Strasbourg.

20/01/26 EVENTS PATIENT EMPOWERMENT PATIENT INVOLVEMENT

2026

03/12/25

EPF Statement on The  Pharmaceutical Legislation

Renewed support to the ambitious objectives of the pharmaceutical package The European Commission's proposal to revise the EU pharmaceutical legislation after 20 years of implementation is an initiative that has been widely welcomed by the patient

Visit the newspage

Upcoming events

Visit the Events page

Interested in becoming a member?

As your advocate, EPF provides many benefits to its members. We represent our members' voice at the European level on cross-cutting health issues.

Our team